The invention provides genetically-modified non-human mammals and genetically-modified
animal cells containing a disrupted RAMP1, RAMP2, or RAMP3 gene. Also provided
by the invention are methods of screening for agents that modulate the activity
or expression of a RAMP and methods of treating mammals to modulate liver function
and/or muscle metabolism.
